FIELD: medical engineering. SUBSTANCE: device has optic part designed as lens from flexible optically transparent hydrogel material and its rest plate is produced from porous collagen copolymer with water-soluble monomers belonging to acryl and vinyl rows containing collagen in the amount of 0.5-10% by mass and sizes vary from 0.1 to 10 mcm. The number of postoperative complications reduces due to concentrated proliferation of porous rest part of the prosthesis with leukoma tissue and absent outflow of fluid from the conjunctival cavity taking place. EFFECT: better biocompatibility properties; low risk of postoperative adverse effects. 2 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PERFORMING KERATOPROSTHETIC TREATMENT OF VASCULAR THINNED LEUKOMA | 1993 |
|
RU2080846C1 |
METHOD OF BEARING MEMBER IMPLANTATION DURING THE FIRST STAGE OF KERATOPROSTHESIS CARRYING OUT | 1993 |
|
RU2079295C1 |
METHOD FOR APPLYING KERATOPROSTHESIS FOR TREATING THE CASES OF THINNED VASCULAR LEUKOMAS | 1999 |
|
RU2179427C2 |
METHOD FOR KERATOPROSTHESIS OF VASCULAR IRREGULAR WALLEYES | 2013 |
|
RU2526881C1 |
METHOD FOR KERATOPROSTHESIS OF VASCULAR COMPLICATED LEUKOMAS OF CATEGORY 4 AND 5 | 2013 |
|
RU2523342C1 |
METHOD FOR PREDICTING ASEPTIC LEUKOMA NECROSIS PROGRESS AFTER THE SECOND STAGE OF KERATOPROSTHETIC REPAIR OPERATION | 2001 |
|
RU2192226C1 |
METHOD FOR KERATOPROSTHESIS OF BURN AND VASCULAR LEUKOMAS (VERSIONS) | 2014 |
|
RU2552304C1 |
KERATOPROSTHESIS | 1997 |
|
RU2124331C1 |
METHOD FOR TREATING KERATOPROSTHESIS PROTRUSION | 1999 |
|
RU2187988C2 |
METHOD FOR KERATOPROSTHESIS OF VASCULAR COMPLICATED LEUKOMAS WITH USING BIOKERATOPROSTHETIC COMPLEX | 2010 |
|
RU2444340C1 |
Authors
Dates
1998-01-27—Published
1995-05-16—Filed